DSI to collaborate with Faculty of Medicine, University of Colombo
View(s):
At the signing of the MOU.
D. Samson Industries recently signed a Memorandum of Understanding (MoU) with the Faculty of Medicine University of Colombo (FOMUOC), with the objective of collaborating in the production of a Beta Brand-Diabetic Shoe Range.
Prof. Chandrika Wijeyaratne, Vice Chancellor of the University of Colombo; Kasun Rajapaksa, Managing Director of D. Samson Industries (Pvt) Ltd; Prof. Vajira Dissanayake, Dean, Faculty of Medicine University of Colombo; Prof. Mandika Wijeyaratne, Head Department of Surgery; Dr. Chathuranga Ranasinghe, Coordinator Sports and Exercise Medicine Unit; Dr. Romain Perera, Dr. Thusitha Kahaduwa, Dilshan Rajapaksa, Director at DSI; Oshini Jayasooriya, Business Development Manager at DSI and Janaka Bandara, Assistant Business Development Manager at DSI were among those present at the signing of the MoU, according to a media release issued by DSI.
The number of diabetic patients in Sri Lanka is currently growing at an alarming level which calls for urgent medical attention and focus from medical authorities such as FOMUOC and SLMA. Beta diabetic shoes, produced by D. Samson Industries (Pvt) Ltd, are specially designed shoes intended to offer protection for diabetic feet and reduce the risk of skin breakdown, primarily in case of poor circulation, neuropathy and foot abnormalities. It is necessary to make diabetic patients aware of the benefits of this diabetic footwear, which can protect their feet in every level.
“Beta diabetic shoes are designed with a protective interior made with soft material and with no stitching, as sometimes even the smallest prominence can irritate and cause skin breakdown in diabetic foot. The top of the shoe is soft and stretchable to suit tender and deformed feet. In addition, beta diabetic shoes contain special insoles that provide support, conform to the contours of the foot and reduce pressure on the bottom of the foot. The specially designed lightweight soles of the shoes are designed to facilitate ease of mobility,” it said.
The continuous improvement and development of the beta brand diabetic footwear will be undertaken with technical advice, research and support from the Faculty of Medicine University of Colombo. With the added advice and consultation of the NIROGI Lanka project of the Sri Lanka Medical Association, this footwear will be of optimal use to diabetic patients.